Women's Health

What Causes Heart Palpitations with PCOS?

Heart palpitations affect a surprising number of women with PCOS — not because of heart disease, but because of the metabolic and hormonal chaos PCOS creates. From insulin-driven adrenaline surges to magnesium wasting and autonomic imbalance, the triggers are specific, measurable, and largely addressable with the right protocol.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·9 min read
PCOSheart palpitationsinsulin resistancemagnesium deficiencyautonomic dysfunctionwomen's health
What Causes Heart Palpitations with PCOS?

What Causes Heart Palpitations with PCOS?

Yes, PCOS directly raises your risk of heart palpitations through several overlapping mechanisms. Insulin resistance — present in up to 70% of women with PCOS — triggers compensatory hyperinsulinemia that stimulates the sympathetic nervous system, accelerating heart rate. The main caveat: palpitations with PCOS are rarely caused by one thing alone, and the mix differs by individual. Women with lean PCOS tend to be driven more by autonomic dysfunction, while those with metabolic PCOS are more often driven by glucose volatility and electrolyte depletion.

---

Why PCOS Creates the Perfect Storm for Palpitations

Polycystic ovary syndrome is fundamentally a hormonal and metabolic condition, and the heart feels the consequences of both. The autonomic nervous system — the system that governs your resting heart rate, heart rate variability (HRV), and sympathovagal balance — is measurably dysregulated in women with PCOS compared to controls.

A 2012 study published in Clinical Endocrinology found that women with PCOS had significantly lower HRV and higher sympathetic nerve activity at rest, independent of BMI (Tekin et al., Clinical Endocrinology 2012; PMID: 22300483). Lower HRV means the heart is less adaptable — it stays in a higher-arousal state, making palpitations, skipped beats, and racing episodes more likely, especially during hormonal fluctuations like ovulation or the luteal phase.

This autonomic imbalance is compounded by the androgenic environment. Elevated testosterone and LH surges — hallmarks of PCOS — have direct chronotropic effects on the heart. In animal models and human data, androgens increase sympathetic outflow and reduce vagal tone, both of which prime the heart for arrhythmic episodes (Dart et al., Hypertension 2009; PMID: 19470883).

The picture becomes even more complex when you consider that LH pulses in PCOS are both more frequent and of greater amplitude than in healthy controls. Each LH surge acts as a peripheral adrenergic stimulus, nudging the heart toward higher rate and ectopic activity. Women with PCOS typically have 1.5–2× the LH pulse frequency of controls, meaning this adrenergic load is essentially continuous across the cycle rather than confined to a single ovulatory window.

If you've also noticed that your palpitations cluster around your cycle, you're not imagining it — you can read more about that pattern in the context of what causes heart palpitations with PMS. If your PCOS coexists with a thyroid condition — which is disproportionately common — the interaction is explored in detail in what causes heart palpitations in perimenopause with hypothyroidism.

---

Insulin Resistance and Blood Sugar Swings: The Most Underdiagnosed Trigger

Insulin resistance is the most common metabolic feature of PCOS, affecting between 50–70% of women regardless of weight (Diamanti-Kandarakis & Dunaif, Endocrine Reviews 2012; PMID: 23065822). When cells resist insulin's signal, the pancreas compensates by secreting more of it. This chronic hyperinsulinemia has a well-documented cardiovascular effect: it activates the sympathetic nervous system directly, raising resting heart rate and increasing the likelihood of ectopic beats.

Beyond the direct autonomic effect, insulin-resistant women experience wider glycemic swings — rapid rises after carbohydrate-heavy meals followed by reactive hypoglycemia. That blood sugar drop is itself a potent palpitation trigger. Epinephrine (adrenaline) is released to bring glucose back up, and adrenaline makes the heart race.

The mechanism is precise: during a hypoglycemic episode — defined clinically as blood glucose below 70 mg/dL — plasma epinephrine concentrations rise 3–5-fold within minutes. Even subclinical drops, from 110 mg/dL to 75 mg/dL in a short window, produce measurable increases in heart rate and QT-interval prolongation, a marker of cardiac electrical instability. Continuous glucose monitoring (CGM) data from insulin-resistant women without diabetes routinely shows these rapid intra-day swings, many of which the wearer never consciously registers as a hypoglycemic episode — they just feel their heart flutter.

Key biomarkers to request from your doctor:

BiomarkerTarget RangeWhy It Matters for Palpitations
Fasting insulin< 10 μIU/mLElevated fasting insulin signals compensatory hyperinsulinemia
HOMA-IR< 2.0Best single calculated marker of insulin resistance
Fasting glucose70–99 mg/dLBaseline metabolic health
2-hr postprandial glucose< 140 mg/dLIdentifies reactive glucose spikes
HbA1c< 5.7%Long-term glucose average
Fasting C-peptide0.8–3.1 ng/mLConfirms pancreatic insulin output

Addressing insulin resistance — through low-glycemic eating patterns, resistance training, and targeted supplementation — typically reduces palpitation frequency significantly in this subgroup. A 16-week trial of a low-glycemic diet in women with PCOS showed a 33% reduction in fasting insulin alongside self-reported improvement in cardiovascular symptoms including palpitations (Marsh et al., American Journal of Clinical Nutrition 2010; PMID: 20130071).

---

Magnesium Deficiency: The Electrolyte Your Heart Cannot Afford to Lose

Magnesium is a cofactor in over 300 enzymatic reactions, including the sodium-potassium ATPase pump that maintains the electrochemical gradient across cardiac cell membranes. When magnesium is low, cardiac cells become electrically unstable — palpitations, premature ventricular contractions (PVCs), and irregular rhythms follow.

Women with PCOS are disproportionately magnesium-deficient for two reasons. First, insulin resistance impairs renal magnesium reabsorption, so higher circulating insulin literally causes the kidneys to waste magnesium (Barbagallo & Dominguez, Archives of Biochemistry and Biophysics 2007; PMID: 17081498). Second, chronic low-grade inflammation — another PCOS feature — increases urinary magnesium excretion.

Standard serum magnesium tests catch only the most severe deficiency because the body maintains serum levels at the expense of intracellular stores. Red blood cell (RBC) magnesium is a more sensitive marker. Optimal RBC magnesium sits above 5.5 mg/dL; many PCOS patients fall between 4.0–5.0 mg/dL and are told their levels are "normal" on a serum panel.

The clinical consequence of this gap is significant. A 2015 meta-analysis of 11 randomized controlled trials found that magnesium supplementation produced a statistically significant reduction in systolic and diastolic blood pressure in adults with low magnesium status, an effect that also correlated with improved cardiac rhythm stability (Kass et al., European Journal of Clinical Nutrition 2012; PMID: 22205694). For PCOS specifically, magnesium repletion also improves insulin sensitivity independently — providing a dual benefit for palpitation reduction.

The form of magnesium matters considerably. Magnesium oxide, the cheapest and most commonly sold form, has less than 4% bioavailability in some studies. Magnesium glycinate — a chelated form — achieves substantially higher absorption, avoids the laxative effect common with oxide and citrate at therapeutic doses, and crosses into muscle and cardiac tissue efficiently. Clinical trials for cardiovascular and neuromuscular outcomes typically use glycinate or bisglycinate at 300–400 mg elemental magnesium per day.

---

Inflammation, Cortisol, and the Stress-Palpitation Loop

Chronic low-grade inflammation is a defining biochemical feature of PCOS, not a side effect. Elevated CRP, IL-6, and TNF-α are consistently documented in PCOS populations independent of obesity (González et al., Human Reproduction 2012; PMID: 22343550). This inflammatory milieu has direct cardiac consequences: it increases oxidative stress in the myocardium, impairs endothelial function, and sensitizes the sinoatrial node — the heart's natural pacemaker — to adrenergic input.

Cortisol compounds the problem. Women with PCOS show blunted cortisol awakening response in some studies but exaggerated cortisol reactivity to psychological stressors in others. Either pattern disrupts the HPA-autonomic axis. When cortisol is chronically elevated, it directly sensitizes adrenergic receptors in the heart, meaning that the same adrenaline stimulus that would cause a mild heart rate increase in a healthy person causes a more pronounced and prolonged one in a woman with PCOS and elevated cortisol.

The practical read-through: if your palpitations are worst in the morning, after meals, or during stress, the cortisol-sympathetic amplification loop is likely a primary driver — not just a contributing factor. Morning palpitations in particular often reflect the combination of an elevated cortisol awakening response and overnight fasting-related hypoglycemia converging on a heart that already has reduced HRV from autonomic dysregulation.

For women whose PCOS presents alongside heavier periods, the picture is further complicated by iron depletion — a separate palpitation driver covered in detail at what causes heart palpitations during a heavy period.

---

Are These Palpitations Dangerous? Reading the Risk Correctly

Most palpitations in PCOS are functional — driven by the mechanisms above — rather than structural or arrhythmic in the pathological sense. However, PCOS independently raises lifetime cardiovascular risk, and that context matters.

Women with PCOS have a 2–3× increased risk of metabolic syndrome and a meaningfully elevated risk of hypertension by their 30s and 40s. This does not mean every palpitation is dangerous, but it does mean the threshold for investigation should be lower than in the general population. Palpitations that are regular (rhythmic, rapid, and sustained), occur with chest pain or syncope, or that show up on a wearable as consistently elevated resting heart rate above 100 BPM warrant an ECG and cardiac evaluation.

For context on how common these experiences are across PCOS presentations, see are heart palpitations normal in PCOS, which walks through the frequency data and when to escalate.

Palpitations that are intermittent, triggered by meals, stress, or the luteal phase, and resolve within seconds are almost always benign in the absence of structural disease — but they are still meaningful signals that the metabolic and autonomic systems need support.

---

What This Means for Your Formula

Because PCOS-related palpitations stem from insulin resistance, autonomic dysregulation, electrolyte depletion, and inflammation — not from a single deficiency — the most effective supplement approach is layered and biomarker-guided.

Ones builds personalized capsule formulas based on uploaded lab results and health history, which is particularly relevant here because the "right" support depends on which mechanism is dominant in your case. Three ingredients are particularly well-matched to this PCOS-palpitation overlap:

Magnesium Glycinate (300–400 mg elemental): Ones includes magnesium glycinate at clinical-range doses, targeting the RBC magnesium deficit common in insulin-resistant women. At this dose and form, it addresses both cardiac electrical stability and insulin sensitivity simultaneously — two of the three major palpitation drivers in PCOS.

Ashwagandha KSM-66 (600 mg): Ones uses the KSM-66 extract standardized to withanolides, the form studied in a randomized, double-blind trial of 64 chronically stressed adults that showed a 27.9% reduction in serum cortisol after 60 days (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). For PCOS women whose palpitations are driven by the cortisol-sympathetic amplification loop, reducing cortisol reactivity reduces the adrenergic sensitivity that makes the heart so responsive to minor stressors.

Omega-3 (EPA/DHA): Chronic inflammation in PCOS is partly driven by an imbalanced omega-6:omega-3 ratio. EPA and DHA have well-documented anti-inflammatory and anti-arrhythmic properties — the GISSI-Prevenzione trial established that 1g/day EPA+DHA reduced sudden cardiac death by 45% in post-MI patients, and the mechanism (reduced ventricular excitability) is relevant to PVC-type palpitations even outside that population. Ones includes EPA/DHA dosed to support this anti-inflammatory and cardiac-stability function.

Because these mechanisms interact — cortisol worsens insulin resistance, insulin resistance depletes magnesium, low magnesium amplifies cortisol sensitivity — addressing all three together produces nonlinear benefit. That is exactly the kind of layered protocol a biomarker-guided approach like Ones is designed to build.

---

Key Takeaways

  • Insulin resistance is the dominant driver for most women with PCOS: hyperinsulinemia activates the sympathetic nervous system, and reactive hypoglycemia floods the body with adrenaline — both trigger palpitations.
  • Autonomic dysregulation is measurable and independent of weight: women with PCOS have lower HRV and higher resting sympathetic tone regardless of BMI, making the heart intrinsically more excitable.
  • Magnesium wasting is a direct consequence of insulin resistance: RBC magnesium is the correct test; serum magnesium misses most cases. Magnesium glycinate at 300–400 mg is the clinically preferred repletion form.
  • Cortisol and inflammation amplify every other mechanism: elevated CRP and cortisol reactivity make the sinoatrial node hyper-responsive to adrenaline — which is why stress feels so much worse in PCOS than in healthy controls.
  • Most PCOS-related palpitations are benign but meaningful: they signal metabolic dysregulation that warrants a targeted biomarker panel, not just reassurance.
  • The protocol is layered: address insulin resistance first, repletion magnesium second, and modulate cortisol-sympathetic tone third — each step reduces palpitation frequency through a distinct and additive mechanism.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading